






This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Outpatient treatment offers flexible therapeutic and medical care without the need to stay overnight in a hospital or inpatient facility. Some centers off intensive outpatient program (IOP), which falls between inpatient care and traditional outpatient service.
Recovery.com has connected directly with this treatment provider to validate the information in their profile.
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Outpatient treatment offers flexible therapeutic and medical care without the need to stay overnight in a hospital or inpatient facility. Some centers off intensive outpatient program (IOP), which falls between inpatient care and traditional outpatient service.
Every policy is different, but treatment at our facilities is covered by many insurance plans including Medicaid. Since we have several locations in Tennessee and Virginia, costs may vary. Your Admissions Specialist will help you understand your costs and what your insurance policy covers.
ReVIDA Recovery Center in Duffield provides outpatient care for clients with opioid use disorders, specializing in medication-assisted treatments (MAT) with Suboxone. Their care team includes licensed therapists, counselors, care coordinators, and peer recovery specialists who are dedicated to guiding and supporting each client in their recovery journey.
Following an initial consultation, clients can begin treatment with Suboxone under the guidance of a dedicated team of prescribers and therapists. Clients also have access to 1-on-1, family, and group therapy, care coordination, and referrals to community resources. Patient care coordinators work with clients to connect them to employment opportunities, educational programs, extended therapy options, and more.
At ReVIDA Recovery, the treatment process is designed to be efficient and flexible to fit clients' busy schedules, with sessions typically lasting between 15 and 50 minutes. ReVIDA accepts most major insurance plans, and offers treatment scholarships for uninsured Tennessee residents who qualify. The clinic is open Monday, Wednesday-Friday 8 AM to 5 PM and Tuesday 9 AM to 6 PM.
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
CARF stands for the Commission on Accreditation of Rehabilitation Facilities. It's an independent, non-profit organization that provides accreditation services for a variety of healthcare services. To be accredited means that the program meets their standards for quality, effectiveness, and person-centered care.
Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT

Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.

Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.